Current Status and Future Prospects of Histopathology in Cancer Diagnosis

A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Mechanisms of Diseases".

Deadline for manuscript submissions: 20 January 2025 | Viewed by 100

Special Issue Editors


E-Mail Website
Guest Editor
Division of Pathology, Department of Diagnostics and Public Health, Azienda Ospedaliera Universitaria Integrata of Verona, 37134 Verona, Italy
Interests: histopathology; immunohistochemistry; neuropathology; dermatopathology; molecular biology; epigenetics; cancer diagnosis; cancer biomarkers; prognostic markers

E-Mail Website
Guest Editor
Department of Diagnostics and Public Health, P.le L.A. Scuro, University of Verona, 37129 Verona, Italy
Interests: cancer biology; colorectal cancer; neuropathology; surgical pathology; prognostic markers; cancer biomarkers; can-cer diagnostics; molecular biology
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

In recent years, the field of histopathology has undergone several innovations, and tissue analysis has substantially contributed to improving the current knowledge on cancer pathophysiology. Indeed, advancements in the fields of cancer genomics and epigenomics have allowed for the identification of new tumor entities and the refinement of histological classifications.

Nonetheless, the backbone of these new discoveries remains the eye of the pathologist, who, starting from the glass (or, more recently, the virtual) slide, delineates the steps to bring about the correct diagnosis and most appropriate treatment for patients.

We are pleased to announce the launch of this new Special Issue, entitled “Current Status and Future Prospects of Histopathology in Cancer Diagnosis”, of the Journal of Personalized Medicine.

This Special Issue aims to highlight the most recent advances in the field of oncological histopathology and welcome original research articles and systematic reviews focused on cutting-edge discoveries in cancer diagnostics, with particular interest in studies that aim to identify correlations between tumor morphology and immunophenotypical and/or molecular features in human cancers. We also encourage fellow researchers to submit articles on new tissue biomarkers that may provide prognostic information and aid in selecting the most appropriate therapeutic strategies for patients with cancer.

Dr. Serena Ammendola
Dr. Valeria Barresi
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • histopathology
  • cancer diagnostics
  • cancer biology
  • prognostic markers
  • targeted therapy
  • immunohistochemistry
  • molecular biology
  • digital pathology
  • artificial intelligence

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop